CytoMed Therapeutics Beheer
Beheer criteriumcontroles 2/4
CytoMed Therapeutics' CEO is Wee Kiat Tan, appointed in Feb 2019, has a tenure of 5.75 years. total yearly compensation is SGD116.30K, comprised of 98.3% salary and 1.7% bonuses, including company stock and options. directly owns 0.043% of the company’s shares, worth $11.53K. The average tenure of the management team and the board of directors is 5.5 years and 1.6 years respectively.
Belangrijke informatie
Wee Kiat Tan
Algemeen directeur
S$116.3k
Totale compensatie
| Percentage CEO-salaris | 98.3% |
| Dienstverband CEO | 5.8yrs |
| Eigendom CEO | 0.04% |
| Management gemiddelde ambtstermijn | 5.5yrs |
| Gemiddelde ambtstermijn bestuur | 1.6yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -S$3m |
| Mar 31 2024 | n/a | n/a | -S$4m |
| Dec 31 2023 | S$116k | S$114k | -S$4m |
| Sep 30 2023 | n/a | n/a | -S$4m |
| Jun 30 2023 | n/a | n/a | -S$4m |
| Mar 31 2023 | n/a | n/a | -S$4m |
| Dec 31 2022 | S$90k | S$87k | -S$3m |
| Sep 30 2022 | n/a | n/a | -S$3m |
| Jun 30 2022 | n/a | n/a | -S$2m |
| Mar 31 2022 | n/a | n/a | -S$2m |
| Dec 31 2021 | S$83k | S$83k | -S$2m |
| Sep 30 2021 | n/a | n/a | -S$2m |
| Jun 30 2021 | n/a | n/a | -S$2m |
| Mar 31 2021 | n/a | n/a | -S$2m |
| Dec 31 2020 | S$80k | S$80k | -S$2m |
Compensatie versus markt: Wee Kiat's total compensation ($USD87.71K) is below average for companies of similar size in the US market ($USD655.65K).
Compensatie versus inkomsten: Wee Kiat's compensation has increased whilst the company is unprofitable.
CEO
Wee Kiat Tan (37 yo)
5.8yrs
Tenure
S$116,302
Compensatie
Dr. Wee Kiat Tan, Ph D., serves as Chief Operating Officer of CytoMed Therapeutics Limited since February 2019 and also serves as its Director since April 18, 2023. He serves as Co-Chief Executive Officer...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 6.7yrs | S$36.05k | 5.18% $ 1.4m | |
| Co-CEO, COO & Director | 5.8yrs | S$116.30k | 0.043% $ 11.5k | |
| Chief Scientific & Medical Officer and Director | 5.3yrs | S$118.43k | 5.11% $ 1.4m | |
| Chief Financial Officer | 4.7yrs | geen gegevens | geen gegevens | |
| Chief Clinical Officer | 1.6yrs | geen gegevens | 0.80% $ 213.4k | |
| Chief Corporate Officer | 6.4yrs | geen gegevens | geen gegevens |
5.5yrs
Gemiddelde duur
37.5yo
Gemiddelde leeftijd
Ervaren management: GDTC's management team is seasoned and experienced (5.5 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 6.7yrs | S$36.05k | 5.18% $ 1.4m | |
| Co-CEO, COO & Director | 1.6yrs | S$116.30k | 0.043% $ 11.5k | |
| Chief Scientific & Medical Officer and Director | 1.6yrs | S$118.43k | 5.11% $ 1.4m | |
| Independent Director | 1.6yrs | geen gegevens | geen gegevens | |
| Independent Director | 1.6yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 1.6yrs | geen gegevens | geen gegevens | |
| Independent Director | 1.6yrs | geen gegevens | geen gegevens | |
| Independent Director | 1.6yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 1.6yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 1.6yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 1.6yrs | geen gegevens | 7.66% $ 2.0m |
1.6yrs
Gemiddelde duur
57yo
Gemiddelde leeftijd
Ervaren bestuur: GDTC's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.